Additionally, CD69 density on the surface of NKT-like cells from treated CML patients was found significantly increased (MFI: 87.9 ± 22.4 vs. 118.0 ± 59.4; p = 0.00467) when compared to HD (Figures 4B,C). Here, CD69 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.